These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17193223)

  • 1. Synthesis and biological evaluation of new quinazoline and cinnoline derivatives as potential atypical antipsychotics.
    Alvarado M; Barceló M; Carro L; Masaguer CF; Raviña E
    Chem Biodivers; 2006 Jan; 3(1):106-17. PubMed ID: 17193223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin 5-HT2 receptor, dopamine D2 receptor, and alpha 1 adrenoceptor antagonists. Conformationally flexible analogues of the atypical antipsychotic sertindole.
    Andersen K; Liljefors T; Hyttel J; Perregaard J
    J Med Chem; 1996 Sep; 39(19):3723-38. PubMed ID: 8809161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and binding affinity of novel 3-aminoethyl-1-tetralones, potential atypical antipsychotics.
    Alvarado M; Coelho A; Masaguer CF; Raviña E; Brea J; Padín JF; Loza MI
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3063-6. PubMed ID: 15878662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and binding affinity of new pyrazole and isoxazole derivatives as potential atypical antipsychotics.
    Barceló M; Raviña E; Masaguer CF; Domínguez E; Areias FM; Brea J; Loza MI
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4873-7. PubMed ID: 17588750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and binding affinity of potential atypical antipsychotics with the tetrahydroquinazolinone motif.
    Carro L; Raviña E; Domínguez E; Brea J; Loza MI; Masaguer CF
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6059-62. PubMed ID: 19796944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, binding affinity, and molecular docking analysis of new benzofuranone derivatives as potential antipsychotics.
    Aranda R; Villalba K; Raviña E; Masaguer CF; Brea J; Areias F; Domínguez E; Selent J; López L; Sanz F; Pastor M; Loza MI
    J Med Chem; 2008 Oct; 51(19):6085-94. PubMed ID: 18783204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QF2004B, a potential antipsychotic butyrophenone derivative with similar pharmacological properties to clozapine.
    Brea J; Castro M; Loza MI; Masaguer CF; Raviña E; Dezi C; Pastor M; Sanz F; Cabrero-Castel A; Galán-Rodríguez B; Fernández-Espejo E; Maldonado R; Robledo P
    Neuropharmacology; 2006 Aug; 51(2):251-62. PubMed ID: 16697427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformationally constrained butyrophenones with affinity for dopamine (D(1), D(2), D(4)) and serotonin (5-HT(2A), 5-HT(2B), 5-HT(2C)) receptors: synthesis of aminomethylbenzo[b]furanones and their evaluation as antipsychotics.
    Raviña E; Casariego I; Masaguer CF; Fontenla JA; Montenegro GY; Rivas ME; Loza MI; Enguix MJ; Villazon M; Cadavid MI; Demontis GC
    J Med Chem; 2000 Nov; 43(24):4678-93. PubMed ID: 11101359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of heterocyclic carboxamides as potential antipsychotic agents.
    Norman MH; Navas F; Thompson JB; Rigdon GC
    J Med Chem; 1996 Nov; 39(24):4692-703. PubMed ID: 8941382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenylpiperazinylmethylheterocycle derivatives: synthesis and dopamine receptor binding profiles.
    Abadi AH
    Arch Pharm (Weinheim); 2004 Jul; 337(7):383-90. PubMed ID: 15237388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro pharmacological evaluation of a new series of 5-HT1A 5-HT2A and 5-HT2C receptor ligands containing a norbornene nucleus.
    Fiorino F; Severino B; De Angelis F; Perissutti E; Magli E; Frecentese F; Esposito A; Massarelli P; Nencini C; Viti B; Santagada V; Caliendo G
    Pharmazie; 2009 Sep; 64(9):555-64. PubMed ID: 19827295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors.
    Millan MJ; Mannoury la Cour C; Novi F; Maggio R; Audinot V; Newman-Tancredi A; Cussac D; Pasteau V; Boutin JA; Dubuffet T; Lavielle G
    J Pharmacol Exp Ther; 2008 Feb; 324(2):587-99. PubMed ID: 18024789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-cinnamyl-4-(2-methoxyphenyl)piperazines: synthesis, binding properties, and docking to dopamine (D(2)) and serotonin (5-HT(1A)) receptors.
    Penjisević J; Sukalović V; Andrić D; Kostić-Rajacić S; Soskić V; Roglić G
    Arch Pharm (Weinheim); 2007 Sep; 340(9):456-65. PubMed ID: 17763374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 7-[3-(1-piperidinyl)propoxy]chromenones as potential atypical antipsychotics. 2. Pharmacological profile of 7-[3-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)-piperidin-1-yl]propoxy]-3-(hydroxymeth yl)chromen -4-one (abaperidone, FI-8602).
    Bolós J; Anglada L; Gubert S; Planas JM; Agut J; Príncep M; De la Fuente N; Sacristán A; Ortiz JA
    J Med Chem; 1998 Dec; 41(27):5402-9. PubMed ID: 9876110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a new class of potential multifunctional atypical antipsychotic agents targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors: design, synthesis, and effects on behavior.
    Butini S; Gemma S; Campiani G; Franceschini S; Trotta F; Borriello M; Ceres N; Ros S; Coccone SS; Bernetti M; De Angelis M; Brindisi M; Nacci V; Fiorini I; Novellino E; Cagnotto A; Mennini T; Sandager-Nielsen K; Andreasen JT; Scheel-Kruger J; Mikkelsen JD; Fattorusso C
    J Med Chem; 2009 Jan; 52(1):151-69. PubMed ID: 19072656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies towards the identification of a new generation of atypical antipsychotic agents.
    Garzya V; Forbes IT; Gribble AD; Hadley MS; Lightfoot AP; Payne AH; Smith AB; Douglas SE; Cooper DG; Stansfield IG; Meeson M; Dodds EE; Jones DN; Wood M; Reavill C; Scorer CA; Worby A; Riley G; Eddershaw P; Ioannou C; Donati D; Hagan JJ; Ratti EA
    Bioorg Med Chem Lett; 2007 Jan; 17(2):400-5. PubMed ID: 17084080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dibenzazecine compounds with a novel dopamine/5HT2A receptor profile and 3D-QSAR analysis.
    Hamacher A; Weigt M; Wiese M; Hoefgen B; Lehmann J; Kassack MU
    BMC Pharmacol; 2006 Sep; 6():11. PubMed ID: 16978403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoenzymatic synthesis and binding affinity of novel (R)- and (S)-3-aminomethyl-1-tetralones, potential atypical antipsychotics.
    Caro Y; Torrado M; Masaguer CF; Raviña E; Padín F; Brea J; Loza MI
    Bioorg Med Chem Lett; 2004 Feb; 14(3):585-9. PubMed ID: 14741248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, binding affinity and SAR of new benzolactam derivatives as dopamine D3 receptor ligands.
    Ortega R; Raviña E; Masaguer CF; Areias F; Brea J; Loza MI; López L; Selent J; Pastor M; Sanz F
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1773-8. PubMed ID: 19217777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of novel antipsychotic trans-4-(2-(1,2,4,5-tetrahydro-3H-benzo[d]azepin-3-yl)ethyl)cyclohexan-1-amine derivatives targeting dopamine/serotonin receptor subtypes.
    Xu JW; Qi YL; Wu JW; Yuan RX; Chen XW; Li JQ
    Bioorg Med Chem Lett; 2021 Jan; 31():127681. PubMed ID: 33189775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.